Jul 24
|
Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast
|
May 13
|
Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK
|
May 10
|
Azenta Inc (AZTA) Q2 Fiscal 2024 Earnings: Revenue Growth Amid Challenges
|
May 8
|
Azenta Announces CEO Succession Plan
|
May 8
|
Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024
|
May 1
|
Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast
|
Apr 9
|
Azenta, Inc. (NASDAQ:AZTA) Shares Could Be 35% Above Their Intrinsic Value Estimate
|
Apr 1
|
Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report
|
Apr 1
|
Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 12
|
Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
|
Jan 28
|
Investors in Azenta (NASDAQ:AZTA) have seen impressive returns of 117% over the past five years
|
Jan 11
|
Azenta to Host Investor Day on March 14, 2024
|
Jan 9
|
Azenta to Participate in the 26th Annual Needham Growth Conference
|
Jan 1
|
Is It Time To Consider Buying Azenta, Inc. (NASDAQ:AZTA)?
|
Nov 13
|
Azenta Inc (AZTA) Reports Revenue Growth in Q4 and FY 2023 Despite Earnings Pressure
|
Nov 13
|
Azenta Reports Fourth Quarter and Full Year Fiscal 2023 Results, Ended September 30, 2023
|
Nov 13
|
Azenta Announces Actions to Support Ongoing Strategic and Governance Transformation
|
Nov 13
|
Azenta Announces Agreement Between B Medical and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo for a Significant National Universal Health Project
|
Nov 10
|
Azenta to Participate in the Stephens Annual Investment Conference
|
Nov 8
|
Azenta Announces Fiscal 2023 Fourth Quarter and Full Year Earnings Conference Call and Webcast
|